Folate: a possible role in erectile dysfunction?

Abstract A growing body of evidence suggests a role for homocysteine (Hcys) and folate (FA) in erectile function (EF): Hcys appears to impair EF affecting endothelium via several mechanism whereas the role of FA remains to be elucidated, besides decreasing Hcys. To assess correlation between erectile dysfunction (ED) and serum levels of FA, Hcys, and B12, we enrolled 31 patients affected by ED (Group A; age 52.83 ± 11.89 years) and 31 healthy adults (Group B; age 49.14 ± 13.63 years). Fasting blood samples were taken for each subject. ED was assessed by the International Index of Erectile Function-5 (IIEF-5). IIEF-5 mean score was significantly lower in Group A than in Group B (10.71 ± 4.24 versus 23.32 ± 1.33, p < .001). Compared to Group B, Group A also showed significantly lower serum FA levels (5.11 ± 1.79 versus 7.9 ± 3.55 ng/ml, p < .001) and significantly higher serum Hcys levels (13.61 ± 3.55 versus 9.17 ± 2.32 µmol/L, p < .001). No significant correlation was observed between Hcys and FA both groups. Our results showed a significant association among ED, FA deficiency and hyperomocisteinemia. Lack of correlation between FA and Hcys suggests that FA deficit may directly impair EF.

[1]  Z. Zhang,et al.  Elevated serum homocysteine level as an independent risk factor for erectile dysfunction: a prospective pilot case–control study , 2017, Andrologia.

[2]  A. Bozkurt,et al.  Association between serum folic acid level and erectile dysfunction , 2016, Andrologia.

[3]  A. Görlach,et al.  Folic Acid Promotes Recycling of Tetrahydrobiopterin and Protects Against Hypoxia-Induced Pulmonary Hypertension by Recoupling Endothelial Nitric Oxide Synthase. , 2015, Antioxidants & redox signaling.

[4]  Nan Yu,et al.  A new potential risk factor in patients with erectile dysfunction and premature ejaculation: folate deficiency , 2014, Asian journal of andrology.

[5]  A. Gündüz,et al.  A comparison of DSM-IV-TR and DSM-5 definitions for sexual dysfunctions: critiques and challenges. , 2014, The journal of sexual medicine.

[6]  S. Esmaeili,et al.  Assessment of the efficacy of combination therapy with folic acid and tadalafil for the management of erectile dysfunction in men with type 2 diabetes mellitus. , 2013, The journal of sexual medicine.

[7]  M. Crabtree,et al.  Recoupling the Cardiac Nitric Oxide Synthases: Tetrahydrobiopterin Synthesis and Recycling , 2012, Current Heart Failure Reports.

[8]  L. Di Luigi,et al.  Tadalafil alters energy metabolism in C2C12 skeletal muscle cells. , 2011, Acta biochimica Polonica.

[9]  F. Montorsi,et al.  Guidelines on male sexual dysfunction: erectile dysfunction and premature ejaculation. , 2010, European urology.

[10]  R. Segraves.  Considerations for diagnostic criteria for erectile dysfunction in DSM V. , 2010, The journal of sexual medicine.

[11]  A. Hale,et al.  Critical Role for Tetrahydrobiopterin Recycling by Dihydrofolate Reductase in Regulation of Endothelial Nitric-oxide Synthase Coupling , 2009, The Journal of Biological Chemistry.

[12]  B. Levy,et al.  Tetrahydrobiopterin Recycling, a Key Determinant of Endothelial Nitric-oxide Synthase-dependent Signaling Pathways in Cultured Vascular Endothelial Cells* , 2009, Journal of Biological Chemistry.

[13]  F. Iellamo,et al.  The Long-Acting Phosphodiesterase Inhibitor Tadalafil does not Influence Athletes' V·O2max, Aerobic, and Anaerobic Thresholds in Normoxia , 2007, International journal of sports medicine.

[14]  I. Mcdowell,et al.  High‐ but not low‐dose folic acid improves endothelial function in coronary artery disease , 2006, European journal of clinical investigation.

[15]  S. Neubauer,et al.  5-Methyltetrahydrofolate Rapidly Improves Endothelial Function and Decreases Superoxide Production in Human Vessels: Effects on Vascular Tetrahydrobiopterin Availability and Endothelial Nitric Oxide Synthase Coupling , 2006, Circulation.

[16]  F. Rossi,et al.  Myoinositol/folic acid combination for the treatment of erectile dysfunction in type 2 diabetes men: a double-blind, randomized, placebo-controlled study. , 2006, European review for medical and pharmacological sciences.

[17]  E. Ur,et al.  Folic acid improves endothelial dysfunction in type 2 diabetes - an effect independent of homocysteine-lowering , 2006, Vascular medicine.

[18]  U. Das.  Folic acid says NO to vascular diseases. , 2003, Nutrition.

[19]  S. Verma,et al.  Interaction of 5-methyltetrahydrofolate and tetrahydrobiopterin on endothelial function. , 2002, American journal of physiology. Heart and circulatory physiology.

[20]  J. Cappelleri,et al.  Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction , 1999, International Journal of Impotence Research.

[21]  K. Woo,et al.  Folic acid improves arterial endothelial function in adults with hyperhomocystinemia. , 1999, Journal of the American College of Cardiology.

[22]  J. Kastelein,et al.  5-methyltetrahydrofolate, the active form of folic acid, restores endothelial function in familial hypercholesterolemia. , 1998, Circulation.

[23]  W. L. Kenney,et al.  Role of folic acid in nitric oxide bioavailability and vascular endothelial function , 2017, Nutrition reviews.

[24]  W. Hellstrom,et al.  Standardization of vascular assessment of erectile dysfunction: standard operating procedures for duplex ultrasound. , 2013, The journal of sexual medicine.